Prenatal Diagnosis Unit
At the Prenatal Diagnosis Unit (UPD) we detect the existence of congenital defects, disorders or malformations that the foetus may show as it develops, as early as possible. Depending on each case, and always on an individual basis, we advise families during the various stages of the pregnancy and help them to make decisions.
Up to 3% of newborns may have some kind of congenital anomaly or defect. These disorders may be structural or functional, familiar or sporadic, hereditary or not, and may occur in low risk as well as high risk pregnancies for various reasons:
- Consanguinity, the blood relationship between two people
- Family history of some hereditary illness
- History of a complicated pregnancy with a malformation in the future baby
- Isoimmunisation, production of antibodies by the mother which may cause anaemia in the foetus
- Exposure to external factors, such as radiation, infections or consumption of medicines which may have a prejudicial effect on the future baby
In these cases, the pregnancy is monitored much more closely, so that the appearance of any anomaly is detected as soon as possible.
The following tools are used:
- Obstetric ultrasound: throughout the pregnancy to detect anomalies in the foetus and also changes to the chromosomes.
- Screening for chromosome defects:
- Conventional screening: these tests include an ultrasound and a blood test on the mother to rule out chromosome anomalies, such as Down's syndrome, or a congenital heart defect.
- Advanced screening: DNI study of the future baby in the mother’s blood
- Invasive testing: if there is a risk factor, these tests are carried out to confirm or rule out possible anomalies in the future baby. This consists of genetic, microbiological, immunological, haematological and biochemical analysis. As these are more complicated techniques, families are always given detailed information about how they work.
We tare active in all stages of the pregnancy:
- Before conception
- At the start of an at-risk pregnancy
- When a defect is diagnosed in the future baby. Then we assist you through:
- The prognosis
- The potential for treatment
Diseases related to this speciality
- Infections with a risk of vertical transmission
- Toxoplasma (parasite)
Health advice related to this speciality
- General hygiene measures to prevent infections during pregnancy.
- Sleep on your side, to prevent the future baby dying.
Treatments related to this speciality
- Intrauterine foetal transfusion, in the event of foetal anaemia
- Legal termination of the pregnancy
Diagnostic tests related to this speciality
- Screening for chromosome defects:
- Advanced: DNI study of the future baby in the mother’s blood
- Chorionic biopsy
Departments related to this speciality:
We work very closely with the following units:
- Obstetric ultrasound
- Foetal Medicine
- Specialist Obstetrics
- Genetics Department (Clinical and Laboratory)
- Aneuploidy Screening Laboratory
- Microbiology Laboratory
- Clinical Pharmacology Department
- Medical Physics and Radiation Protection Department
- Paediatric Radiology Department (magnetic resonance - MRI)
- Perinatal Psychology
Dr. Elena Carreras, medical coordinator of the Obstetrics and Reproductive Endocrinology Department, explains how the appearance of the ultrasound revolutionised the work of staff and how new intrauterine foetal therapy techniques will mark the future of the Department.
The former head of the Thoracic Surgery Department, Dr. Mercè Canela, recently retired, recalls the important evolution of the Department to become a leader in Spain and a lung transplant pioneer. A task made possible thanks to collaboration with professionals from other departments, an added value in the personal and team environment.
Rosalia Moure arrived at Vall d’Hebron University Hospital in 1967. She spent her entire working life in the linen and laundry department of the Hospital. Rosalia Moure has witnessed the Hospital’s big transformations, from dictatorship to democracy and from analogue to digital systems.
Dr. Josep Sánchez de Toledo Codina, head of the Paediatric Haematology and Oncology Department, tells us about a Department that has laid the foundations for the specialism in Spain. He also remembers the evolution of transplants from haematopoietic stem cells and progenitors, from the beginning, buying the material at a shop in Barcelona city centre, to the more than 1,200 transplants that have now been performed.
Dr. Francesc Bosch, Head of the Haematology Department, talks about the complexity of the Department, which has turned Vall d’Hebron into a reference centre in haematology thanks to its commitment to transplants and the use of new treatments. The Clinical Trials Unit helps a lot, giving access to treatments for complex patients.
The Master's Degree in Biomedical and Translational Research is an official programme created to train researchers with the requisite combination of scientific knowledge and skills to contribute to the future success of biomedical research.
Fermín Fernández Álvarez, Porter Coordinator, explains the importance of the role these professionals play in the hospital. After 36 years at Vall d’Hebron, Fermín is a real master of the ways things are done. He says that a porter has to combine humility, discretion and safety with a single goal: that patients receive human and friendly treatment.